[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Furrer et al., 2013 - Google Patents

Validation of a new classifier for the automated analysis of the human epidermal growth factor receptor 2 (HER2) gene amplification in breast cancer specimens

Furrer et al., 2013

View HTML @Full View
Document ID
1641182211132120332
Author
Furrer D
Jacob S
Caron C
Sanschagrin F
Provencher L
Diorio C
Publication year
Publication venue
Diagnostic pathology

External Links

Snippet

Amplification of the human epidermal growth factor receptor 2 (HER2) is a prognostic marker for poor clinical outcome and a predictive marker for therapeutic response to targeted therapies in breast cancer patients. With the introduction of anti-HER2 therapies, accurate …
Continue reading at link.springer.com (HTML) (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • G01N33/574Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407Specifically defined cancers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06TIMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2207/00Indexing scheme for image analysis or image enhancement
    • G06T2207/30Subject of image; Context of image processing
    • G06T2207/30004Biomedical image processing
    • G06T2207/30024Cell structures in vitro; Tissue sections in vitro
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06TIMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T7/00Image analysis
    • G06T7/0002Inspection of images, e.g. flaw detection
    • G06T7/0012Biomedical image inspection
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06FELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00Digital computing or data processing equipment or methods, specially adapted for specific applications
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Hybridisation probes

Similar Documents

Publication Publication Date Title
Furrer et al. Validation of a new classifier for the automated analysis of the human epidermal growth factor receptor 2 (HER2) gene amplification in breast cancer specimens
Echle et al. Deep learning in cancer pathology: a new generation of clinical biomarkers
Kather et al. Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
Yuan et al. Quantitative image analysis of cellular heterogeneity in breast tumors complements genomic profiling
Zhang et al. Reliability of tissue microarrays in detecting protein expression and gene amplification in breast cancer
Rizzardi et al. Quantitative comparison of immunohistochemical staining measured by digital image analysis versus pathologist visual scoring
US8428887B2 (en) Method for automated processing of digital images of tissue micro-arrays (TMA)
US7760927B2 (en) Method and system for digital image based tissue independent simultaneous nucleus cytoplasm and membrane quantitation
JP2021006037A (en) System and method for calculating immune score
Turashvili et al. Inter-observer reproducibility of HER2 immunohistochemical assessment and concordance with fluorescent in situ hybridization (FISH): pathologist assessment compared to quantitative image analysis
US20130338016A1 (en) Method For Integrated Pathology Diagnosis And Digital Biomarker Pattern Analysis
Liu et al. Reproducible, high-dimensional imaging in archival human tissue by multiplexed ion beam imaging by time-of-flight (MIBI-TOF)
Le Page et al. Using a convolutional neural network for classification of squamous and non-squamous non-small cell lung cancer based on diagnostic histopathology HES images
Reljin et al. Breast cancer evaluation by fluorescent dot detection using combined mathematical morphology and multifractal techniques
Conway et al. Virtual microscopy as an enabler of automated/quantitative assessment of protein expression in TMAs
Lara et al. Tumor core biopsies adequately represent immune microenvironment of high-grade serous carcinoma
Khushi et al. MatCol: a tool to measure fluorescence signal colocalisation in biological systems
Minot et al. Automated cellular imaging system III for assessing HER2 status in breast cancer specimens: development of a standardized scoring method that correlates with FISH
Rahman et al. Advances in tissue-based imaging: impact on oncology research and clinical practice
Jamalzadeh et al. QuantISH: RNA in situ hybridization image analysis framework for quantifying cell type-specific target RNA expression and variability
Liu et al. TMA-Combiner, a simple software tool to permit analysis of replicate cores on tissue microarrays
Xue et al. Deep learning to automatically evaluate HER2 gene amplification status from fluorescence in situ hybridization images
Li et al. Automated tumor immunophenotyping predicts clinical benefit from anti‐PD‐L1 immunotherapy
US8693743B1 (en) Analysis and display of multiple biomarker co-expression in cells and tissues
Maus et al. Resolving the heterogeneous tumor-centric cellular neighborhood through multiplexed, spatial paracrine interactions in the setting of immune checkpoint blockade